Pfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug Remdesivir
August 07, 2020 at 11:52 AM EDT
Large-cap biopharma companies Pfizer Inc. and Gilead Sciences, Inc. announced a deal Friday for Gilead's remdesivir, which has been accorded emergency use authorization by the FDA for treating COVID-19.